
CERS Valuation
Cerus Corp
- Overview
- Forecast
- Valuation
- Earnings
CERS Relative Valuation
CERS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CERS is overvalued; if below, it's undervalued.
Historical Valuation
Cerus Corp (CERS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.22 is considered Undervalued compared with the five-year average of -18.42. The fair price of Cerus Corp (CERS) is between 13.03 to 18.71 according to relative valuation methord. Compared to the current price of 1.46 USD , Cerus Corp is Undervalued By 88.8%.
Relative Value
Fair Zone
13.03-18.71
Current Price:1.46
88.8%
Undervalued
-22.37
PE
1Y
3Y
5Y
Trailing
Forward
31.13
EV/EBITDA
Cerus Corp. (CERS) has a current EV/EBITDA of 31.13. The 5-year average EV/EBITDA is -8.36. The thresholds are as follows: Strongly Undervalued below -134.14, Undervalued between -134.14 and -71.25, Fairly Valued between 54.53 and -71.25, Overvalued between 54.53 and 117.42, and Strongly Overvalued above 117.42. The current Forward EV/EBITDA of 31.13 falls within the Historic Trend Line -Fairly Valued range.
-20.37
EV/EBIT
Cerus Corp. (CERS) has a current EV/EBIT of -20.37. The 5-year average EV/EBIT is -22.97. The thresholds are as follows: Strongly Undervalued below -42.76, Undervalued between -42.76 and -32.87, Fairly Valued between -13.07 and -32.87, Overvalued between -13.07 and -3.18, and Strongly Overvalued above -3.18. The current Forward EV/EBIT of -20.37 falls within the Historic Trend Line -Fairly Valued range.
1.22
PS
Cerus Corp. (CERS) has a current PS of 1.22. The 5-year average PS is 4.19. The thresholds are as follows: Strongly Undervalued below -1.75, Undervalued between -1.75 and 1.22, Fairly Valued between 7.16 and 1.22, Overvalued between 7.16 and 10.12, and Strongly Overvalued above 10.12. The current Forward PS of 1.22 falls within the Historic Trend Line -Fairly Valued range.
43.73
P/OCF
Cerus Corp. (CERS) has a current P/OCF of 43.73. The 5-year average P/OCF is 36.51. The thresholds are as follows: Strongly Undervalued below -274.16, Undervalued between -274.16 and -118.82, Fairly Valued between 191.84 and -118.82, Overvalued between 191.84 and 347.18, and Strongly Overvalued above 347.18. The current Forward P/OCF of 43.73 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Cerus Corp. (CERS) has a current P/FCF of 0.00. The 5-year average P/FCF is -1.80. The thresholds are as follows: Strongly Undervalued below -36.51, Undervalued between -36.51 and -19.15, Fairly Valued between 15.56 and -19.15, Overvalued between 15.56 and 32.92, and Strongly Overvalued above 32.92. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Cerus Corp (CERS) has a current Price-to-Book (P/B) ratio of 5.05. Compared to its 3-year average P/B ratio of 6.76 , the current P/B ratio is approximately -25.33% higher. Relative to its 5-year average P/B ratio of 8.68, the current P/B ratio is about -41.85% higher. Cerus Corp (CERS) has a Forward Free Cash Flow (FCF) yield of approximately 1.22%. Compared to its 3-year average FCF yield of -5.47%, the current FCF yield is approximately -122.38% lower. Relative to its 5-year average FCF yield of -4.85% , the current FCF yield is about -125.19% lower.
5.22
P/B
Median3y
6.76
Median5y
8.68
1.22
FCF Yield
Median3y
-5.47
Median5y
-4.85
Competitors Valuation Multiple
The average P/S ratio for CERS's competitors is 2.30, providing a benchmark for relative valuation. Cerus Corp Corp (CERS) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 19.02%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of CERS decreased by 16.09% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 50.52M to 60.13M.
The secondary factor is the Margin Expansion, contributed -16.89%to the performance.
Overall, the performance of CERS in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch

MBX
MBX Biosciences Inc
20.000
USD
+100.00%

CIX
CompX International Inc
24.460
USD
-2.04%

CIVB
Civista Bancshares Inc
20.690
USD
-0.48%

NMRA
Neumora Therapeutics Inc
1.730
USD
-1.70%

ZBIO
Zenas Biopharma Inc
18.950
USD
+0.05%

NETD
Nabors Energy Transition Corp II
11.220
USD
-0.88%

BRT
BRT Apartments Corp
16.390
USD
+1.30%

YSG
Yatsen Holding Ltd
9.860
USD
-0.60%

HBANL
Huntington Bancshares Inc
26.050
USD
+0.39%

TRVI
Trevi Therapeutics Inc
8.550
USD
+4.91%
FAQ

Is Cerus Corp (CERS) currently overvalued or undervalued?
Cerus Corp (CERS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.22 is considered Undervalued compared with the five-year average of -18.42. The fair price of Cerus Corp (CERS) is between 13.03 to 18.71 according to relative valuation methord. Compared to the current price of 1.46 USD , Cerus Corp is Undervalued By 88.80% .

What is Cerus Corp (CERS) fair value?

How does CERS's valuation metrics compare to the industry average?

What is the current P/B ratio for Cerus Corp (CERS) as of Sep 23 2025?

What is the current FCF Yield for Cerus Corp (CERS) as of Sep 23 2025?

What is the current Forward P/E ratio for Cerus Corp (CERS) as of Sep 23 2025?
